MedPath

Prospective evaluation of the comparability of different imaging methods for the detection and characterization of sentinel lymph nodes in cervical cancer and endometrial carcinoma

Conditions
C54.1
C53
Endometrium
Malignant neoplasm of cervix uteri
Registration Number
DRKS00014346
Lead Sponsor
niversitätsklinikum Tübingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
362
Inclusion Criteria

Patients with cervical cancer or endometrial cancer with a clinical indication for PET/MRT-examination for i) primary staging or re-staging in advanced disease, ii) unclear diagnosis based on conventional imaging procedures for op-planning, iii) pre-op exclusion of pelvine metastasis in case of pelvine relapse
- Age: =18 years
- Written informent consent

Exclusion Criteria

- Histologic type of carcinosarcoma or other rare entities
- Precnancy or breast feeding women
- No written informed consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of different imaging methods for the detection of SLN (SPECT/CT, intra-op staining methods, PET/MRT) – among each other and in correlation to gold standard (immunohistological analysis) – for the pre-op localization of tumor-positive / tumor-negative S
Secondary Outcome Measures
NameTimeMethod
What is the predictive value of the combination of different imaging methods for tumor-positive SLN?<br>To do so: evaluation of sensitivity, specificity, accuracy as well as positive/negative predictive value of single imaging methods or combinations thereof for the detection of positive/negative SLN in patients with endometrial or cervical cancer – compared to gold standard (histopathological analyses of SLN).<br>
© Copyright 2025. All Rights Reserved by MedPath